Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
See detailFictions du champ littéraire
Brissette, Pascal; Dozo, Björn-Olav ULg; Glinoer, Anthony et al

Book published by Discours social (2010)

Detailed reference viewed: 12 (3 ULg)
Full Text
Peer Reviewed
See detailLes fictions en droit
Biquet, Christine ULg

in Revue de la Faculté de Droit de l'Université de Liège (2013), (1), 2551

Detailed reference viewed: 11 (1 ULg)
Full Text
Peer Reviewed
See detailLes fictions en droit
Biquet, Christine ULg

in Hanyang Law Review (2013), 30(1), 275-305

Detailed reference viewed: 14 (5 ULg)
Full Text
See detailFictions, figurations, configurations : introduction à un projet
Brissette, Pascal; Dozo, Björn-Olav ULg; Glinoer, Anthony et al

in Discours social (2010), XXXIV

Detailed reference viewed: 30 (3 ULg)
Full Text
Peer Reviewed
See detailFidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.
Crook, Derrick W.; Walker, A. Sarah; Kean, Yin et al

in Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America (2012), 55 Suppl 2

Two recently completed phase 3 trials (003 and 004) showed fidaxomicin to be noninferior to vancomycin for curing Clostridium difficile infection (CDI) and superior for reducing CDI recurrences. In both ... [more ▼]

Two recently completed phase 3 trials (003 and 004) showed fidaxomicin to be noninferior to vancomycin for curing Clostridium difficile infection (CDI) and superior for reducing CDI recurrences. In both studies, adults with active CDI were randomized to receive blinded fidaxomicin 200 mg twice daily or vancomycin 125 mg 4 times a day for 10 days. Post hoc exploratory intent-to-treat (ITT) time-to-event analyses were undertaken on the combined study 003 and 004 data, using fixed-effects meta-analysis and Cox regression models. ITT analysis of the combined 003/004 data for 1164 patients showed that fidaxomicin reduced persistent diarrhea, recurrence, or death by 40% (95% confidence interval [CI], 26%-51%; P < .0001) compared with vancomycin through day 40. A 37% (95% CI, 2%-60%; P = .037) reduction in persistent diarrhea or death was evident through day 12 (heterogeneity P = .50 vs 13-40 days), driven by 7 (1.2%) fidaxomicin versus 17 (2.9%) vancomycin deaths at <12 days. Low albumin level, low eosinophil count, and CDI treatment preenrollment were risk factors for persistent diarrhea or death at 12 days, and CDI in the previous 3 months was a risk factor for recurrence (all P < .01). Fidaxomicin has the potential to substantially improve outcomes from CDI. [less ▲]

Detailed reference viewed: 8 (0 ULg)
See detailFidelité de la réparation de l'ADN
Muller, Marc ULg

Doctoral thesis (1986)

Detailed reference viewed: 7 (3 ULg)
Full Text
Peer Reviewed
See detailFidélité et Substitution : Effets de l’Etendue et de la Durée des Ruptures de Stock sur le Comportement du Consommateur
Brandt, Céline ULg; Pahud de Mortanges, Charles ULg; Van Riel, Allard ULg

Conference (2011, May)

Our research presents three types of stock outs: the traditional stock out, the prolonged stock out and the brand prolonged stock out. The research question is as follows: « Is the consumer going to stay ... [more ▼]

Our research presents three types of stock outs: the traditional stock out, the prolonged stock out and the brand prolonged stock out. The research question is as follows: « Is the consumer going to stay loyal to the store by choosing a substitute or is he going to chose another retail store? » [less ▲]

Detailed reference viewed: 28 (3 ULg)
Full Text
See detailFidélité intercotateurs de l'échelle psychopathologique AMDP II. Distances entre cotateurs et analyse d'items d'une délirante et d'une déprimée
Mirel, J.; Von Frenckell, R.; Berner, P. et al

in Compte rendu du Congrès de Psychiatrie et de Neurologie de Langue Française (1979), 57

Detailed reference viewed: 22 (7 ULg)
Peer Reviewed
See detailFidelity Discounts and Rebates not Justified by Costs
Petit, Nicolas ULg

Conference (2008, April 17)

Detailed reference viewed: 28 (1 ULg)
Peer Reviewed
See detailFidi interpretes. La traduction orale à Rome
Rochette, Bruno ULg

in Ancient Society (1996), 27

Detailed reference viewed: 30 (0 ULg)
Full Text
See detailField bordering flower strips as source of lipids
Paul, Aman ULg; Danthine, Sabine ULg; Stephanie, Heuskin et al

Poster (2014, February 07)

Field bordering flower strips not just only improves the biodiversity but also serves as a source of beneficial compounds. Some of the plants in these strips can be really interesting source of lipids ... [more ▼]

Field bordering flower strips not just only improves the biodiversity but also serves as a source of beneficial compounds. Some of the plants in these strips can be really interesting source of lipids, the oils extracted from their seeds can be important for food, pharmaceutical and cosmetics industries. Six species of plants from flowering strips in Belgium were investigated for their seed oil content. The oil from seeds was extracted by cold extraction technique using chloroform/methanol in 2:1 ratio as solvent. Oil extraction from seeds of Red Clover (Trifolium pratense), Rough Hawkbit (Leontodon hispidus), Cow Parsley (Anthriscus sylvestris), St John’s Wort (Hypericum perforatum), Common Yarrow (Achillea millefollium) and Birdsfoot Trefoil (Lotus corniculatus) plant species was done on wet weight which came out to be 7.89±0.11%, 11.86±0.07%, 14.78±0.31%, 24.20±0.02%, 20.08±0.15% and 7.04±0.12% respectively. The physicochemical properties of the extracted oils were analyzed. Some of these oils can be of great commercial value. [less ▲]

Detailed reference viewed: 20 (5 ULg)
Full Text
See detailField campaigns: pumping tests and tracer tests
Brouyère, Serge ULg; Bretotean, Mihai; Minciuna, Marin-Nelu et al

in Hidrotehnica (2004), 49(9-10), 36-50

Detailed reference viewed: 47 (1 ULg)
Peer Reviewed
See detailField Efficacy of Injectable and Pour-on Moxidectin in Cattle Naturally Infested with Psoroptes Ovis (Acarina: Psoroptidae)
Lonneux, J. F.; Losson, Bertrand ULg

in Veterinary Parasitology (1992), 45(1-2), 147-52

Field efficacy of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Psoroptes ovis. Three groups of six animals were used based on parasitological and clinical ... [more ▼]

Field efficacy of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Psoroptes ovis. Three groups of six animals were used based on parasitological and clinical status. Group 1 animals received one subcutaneous injection of injectable moxidectin at 0.2 mg kg-1 body weight; Group 2 animals received topically one dose of 0.5 mg kg-1 body weight of pour-on moxidectin; Group 3 individuals remained untreated as controls. Efficacy was assessed by (a) taking skin samples from each animal on Days -4, 14, 28, 42 and 56 post-treatment (PT) and observing numbers of viable mite stages and species and (b) clinical examination of animals on Days 14, 28, 42 and 56 with the percentage of affected body surface calculated for each animal on Days -4, 28 and 56. Both formulations gave 100% efficacy as no live mites were found in Groups 1 or 2, 14, 28 and 56 days after treatment. Clinical indices showed a sharp decrease in the affected body surface area from a mean of 5.48% and 6.1% on Day -4 in Groups 1 and 2, respectively, to 0% in both groups on Days 28 and 56 PT. All untreated animals remained positive until Day 28. The clinical condition of the controls worsened rapidly during the experiment (mean clinical index: 2.87% and 13.05% on Days -4 and 28, respectively) and they were given an emergency treatment on Day 28. No side-effects were observed with either formulation.(ABSTRACT TRUNCATED AT 250 WORDS) [less ▲]

Detailed reference viewed: 14 (5 ULg)
Full Text
Peer Reviewed
See detailField Efficacy of Injectable Doramectin against Chorioptes Bovis in Naturally Infected Cattle
Losson, Bertrand ULg; Mignon, Bernard ULg; Bossaert, K. et al

in Veterinary Record : Journal of the British Veterinary Association (1998), 142(1), 18-19

A single subcutaneous injection of doramectin at a dose rate of 200 micrograms/kg bodyweight was effective in controlling an infection of Chorioptes bovis mites in naturally infected cattle. From 14 days ... [more ▼]

A single subcutaneous injection of doramectin at a dose rate of 200 micrograms/kg bodyweight was effective in controlling an infection of Chorioptes bovis mites in naturally infected cattle. From 14 days after treatment, the geometric mean number of live mites was significantly lower (P < 0.001) in the doramectin-treated cattle than in the control group at each sampling until day 35. The percentage efficacy (treated versus controls) of doramectin against C bovis at day 35 was 99.9 per cent and the percentage reduction (day 35 versus day 0) in the treated animals was 99.3 per cent. At day 35, all seven controls were still positive for C bovis whereas five of the eight doramectin-treated animals were free of live mites. [less ▲]

Detailed reference viewed: 9 (0 ULg)
Peer Reviewed
See detailField Efficacy of Injectable Moxidectin in Cattle Naturally Infested with Chorioptes Bovis and Sarcoptes Scabiei
Losson, Bertrand ULg; Lonneux, J. F.

in Veterinary Parasitology (1993), 51(1-2), 113-21

Field efficacy of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis and Sarcoptes scabiei. Eight animals were allocated to two groups of four ... [more ▼]

Field efficacy of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis and Sarcoptes scabiei. Eight animals were allocated to two groups of four animals each, based on parasitological and clinical status. Animals of the treated group received one subcutaneous injection of injectable moxidectin at 0.2 mg kg-1 body weight on Day 0. Individuals of the control group received emergency treatment of a single injection of moxidectin at 0.2 mg kg-1 body weight on Day 28. Efficacy was assessed by (a) taking skin samples from each animal on Days 0, 7, 14, 21, 28, 42 and 56 and observing the numbers of viable mite stages and species and (b) clinical examination of animals on Days 7, 14, 21, 28, 42 and 56 with the percentage of affected body surface calculated for each animal on Days 0, 28 and 56. On the basis of the geometric means from treated and control animals, the percentage reductions in the total numbers of living C. bovis mites on Days 7, 14, 21 and 28 were 69, 87, more than 99 and 98, respectively. However, at the end of the trial, only two animals were negative for C. bovis. The percentage reductions in the total numbers of S. scabiei on Days 7, 14, 21 and 28 were 93, 100, 100 and 100, respectively. Clinical indices of the treated animals showed a sharp decrease in the affected body surface area from a mean of 43.6% on Day 0 to 0.9% and 0% on Days 28 and 56, respectively.(ABSTRACT TRUNCATED AT 250 WORDS) [less ▲]

Detailed reference viewed: 19 (3 ULg)
Peer Reviewed
See detailField Efficacy of Moxidectin 0.5% Pour-on against Chorioptes Bovis, Damalinia Bovis, Linognathus Vituli and Psoroptes Ovis in Naturally Infected Cattle
Losson, Bertrand ULg; Lonneux, J. F.

in Veterinary Parasitology (1996), 63(1-2), 119-30

Field efficacy of a pour-on formulation of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis, Damalinia bovis, Linognathus vituli and ... [more ▼]

Field efficacy of a pour-on formulation of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis, Damalinia bovis, Linognathus vituli and Psoroptes ovis. In trial 1, two experimental groups of cattle naturally infested with P. ovis were formed. Group 1 animals remained as untreated controls whereas Group 2 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg-1 bw. Efficacy was assessed by (a) taking skin samples from each animal on days -4, 7, 14, 21, 28, 42 and 56 post treatment (PT) and observing the numbers of viable P. ovis mites and (b) clinical examination of animals on days 7, 14, 21, 28, 42 and 56 with the percentage of affected body surface calculated and live body weights recorded for each animal on days 4, 28 and 42. The pour-on formulation of moxidectin yielded excellent efficacy as no live mites were found in treated animals at 14, 21, 28, 42 and 56 days PT, except in one animal from which one adult mite was collected on day 42. Clinical indices showed a regular decrease in the affected body surface area. All untreated animals but one remained positive until day 28 and their clinical condition worsened rapidly. In trial 2, two experimental groups of cattle naturally infested with D. bovis and L. vituli were selected. Group 1 remained as untreated controls whereas Group 2 individuals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg-1 bw. Efficacy was assessed by identifying and counting lice on eight 15 cm hair partings at predefined anatomical sites on days 0, 14, 28 and 42. On the basis of animals cured and lice count reduction, efficacies were 100% on day 14 and from then onwards for both species. In trial 3, 24 animals naturally infested with C. bovis were divided into three experimental groups comprising eight (Group I), seven (Group 2) and nine animals (Group 3). Group 1 was the untreated control group whereas Groups 2 and 3 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.25 mg and 0.5 mg kg-1 bw, respectively. Efficacy was assessed as in trial 1. Skin scrapings were collected on days -3, 7, 14, 28, 42 and 56 PT. A clinical index was calculated for each animal on days 0, 28 and 56 whereas body weights were recorded on days 0 and 56. At 0.25 mg kg-1 bw, the efficacy of moxidectin cattle pour-on against C. bovis was incomplete. In contrast, at a dose of 0.5 mg kg-1 bw, moxidectin cattle pour-on was fully effective and by day 14 PT all animals were negative for C. bovis and remained so until the end of the trial. No side effects were observed during these three trials. These results indicate that at a dose of 0.5 mg kg-1 bw, the pour-on formulation of moxidectin is highly effective against C. bovis, D. bovis, L. vituli and P. ovis. [less ▲]

Detailed reference viewed: 15 (2 ULg)
Full Text
Peer Reviewed
See detailField evaluation of poor performance in Standardbred trotters
Van Erck, Emmanuelle; Jakesova, V.; Lekeux, Pierre ULg et al

in Pferdeheilkunde (2006), 22

Exercise tests allow evaluating athletic capacity and fitness, following training-induced adaptations and determining causes of poor performance. A retrospective study was conducted over the cases of 40 ... [more ▼]

Exercise tests allow evaluating athletic capacity and fitness, following training-induced adaptations and determining causes of poor performance. A retrospective study was conducted over the cases of 40 poor performing Standardbreds referred to an Equine Sports Medicine consultation at a Belgian racetrack. The study aimed at determining if the implementation of a standardised exercise test and determination of specific athletic parameters could discriminate between the poor performers and a group of eight healthy racehorses and help in establishing a diagnosis. After a through clinical examination, the horses were submitted to an exercise test that consisted of 3 bouts of 1500m at increasing speeds with a recovery phase of 500 m in between. Speed and heart rate were continuously monitored and blood lactate concentrations were evaluated after each step. Pre and post-effort blood work and respiratory endoscopy with sampling were done in each horse. Five main causes of poor performance were identified: locomotor, respiratory, cardiac, muscular problems and inadequate training. In the poor performers group, 24 horses suffered from upper and/or lower respiratory disease, 20 from lameness, 4 from cardiac disease, 4 from exercise-induced myopathy and 5 from maladjusted training. More than half of the horses had multiple problems (23 horses). The fitness parameters (V-LA4, V-200) obtained were useful for inter-individual comparisons and discriminated poor performers from healthy controls, whatever the cause of the intolerance. This study confirms the high prevalence of lameness and respiratory diseases as causes of poor performance in racehorses. The field exercise tests were readily performed with minimal equipment and enabled to identify conditions which were not clearly apparent as during the clinical examination at rest. The recovery of maximum information by a thorough questioning of the trainer and selected ancillary examinations was critical to reach a diagnosis. [less ▲]

Detailed reference viewed: 205 (8 ULg)